Moderna Inc. has just received approval from the UK for a Covid-19 booster shot that targets omicron, the version of the virus that’s now the world’s most widespread.
So far, the shot was provisionally approved in the country for individuals aged six years and older and as a booster dose for those aged 18 years and older, TGA said in a separate statement. The move comes as Australia battles a major virus outbreak fueled by the highly transmissible…
US biotech company Moderna on Wednesday announced positive results for a new vaccine that targets both the original Covid strain and Omicron.